Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Labcorp® Plasma Detect™, the first clinically validated, tumor-informed, whole-genome sequencing circulating tumor DNA (ctDNA) molecular residual disease (MRD) solution in early stage colon cancer .
Labcorp (LH) Launches Labcorp Plasma Detect streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Labcorp® Plasma Detect™,.
Johns Hopkins Develops Method to Detect Cancer from Junk DNA miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Personal Genome Testing MarketThe personal genome testing market is poised for exponential growth, with the latest market forecast projecting a substantial surge. According to market analysis by leading research firms, the global personal genome testing market is anticipated to reach a valuation of US$ 4,468 Million.